EZZ has returned from a prestigious exhibition to showcase a range of its products for mums, babies and toddlers in Vietnam as Australia looks to strengthen ties with the fast-growing Southeast Asian country. Australian life science company EZZ Life Science…
● EAORON has launched an updated product line to hit 350 Chemist Warehouse stores nationally in late April. ● The updated line includes six new products, including the Hyaluronic Acid Glutathione Essence Face Mask. ● The partnership aims to make…
EZZ has signed a contract for service agreement with the University of Auckland to conduct research on anti-aging and immune-stimulation products. EZZ Life Science (ASX: EZZ) said the deal with University of Auckland builds on success of a previous study…
China’s approval of NMN supplements as food additives is expected to launch EZZ further into the Chinese supplements market. EZZ Life Science (ASX:EZZ)’s vitamin products are about to get a huge boost in China, following the regulatory approval of the…
Cameron Drummond Contributor, Advisir info@advisir.com.au EZZ has recognised two important factors for growth: A booming e-Commerce sector and increased consumer interest in health and wellbeing products The expansion of its distribution channels is future-proofing EZZ’s revenue opportunities Market penetration into…
According to Glenn Cross, chair of EZZ Life Science, overall health and wellbeing is never more important than when either starting a family or having another baby. “When parents-to-be are in their peak health condition, it gives your baby the…
EZZ Life Science (EZZ) lifts its operating cashflows during FY22, as it continues to reduce expenses The company gained $1.9 million from its operations, a jump from the $253,533 recorded in FY21 It comes as EZZ sharpens its focus on…
By Louis Allen EZZ Life Science (ASX: EZZ) has announced that despite a challenging start, it enjoyed a strong finish to the financial year ending June (FY2022) – placing it in a robust financial position for future growth. The genomic…
Written by Tess Sanders Lazarus Australian genomic life science company, EZZ Life Science (ASX: EZZ) has posted favourable quarterly results, with the company reporting strong sales results and a healthy cash balance of $10 million plus as of 30 June…